Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza Sells 12,166 Shares

Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 12,166 shares of the company's stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $10.07, for a total value of $122,511.62. Following the sale, the director now owns 731,560 shares in the company, valued at approximately $7,366,809.20. This trade represents a 1.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Saiyed Atiq Raza also recently made the following trade(s):

• On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total transaction of $24,024.00.

Arteris Stock Down 4.2 %

NASDAQ AIP traded down $0.39 on Thursday, reaching $8.95. 183,682 shares of the stock traded hands, compared to its average volume of 167,617. Arteris, Inc. has a 12 month low of $4.83 and a 12 month high of $10.60. The company has a market cap of $359.58 million, a price-to-earnings ratio of -9.32 and a beta of 1.25. The company has a fifty day moving average price of $8.18 and a 200-day moving average price of $7.87. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

Institutional Trading of Arteris

Several institutional investors and hedge funds have recently made changes to their positions in the company. US Bancorp DE bought a new position in Arteris in the third quarter worth approximately $34,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Arteris during the 2nd quarter worth $86,000. Algert Global LLC bought a new stake in Arteris during the second quarter valued at about $115,000. MetLife Investment Management LLC boosted its position in Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock valued at $131,000 after purchasing an additional 9,551 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Arteris during the third quarter valued at approximately $226,000. 64.36% of the stock is currently owned by institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.